Roni Donan has extensive experience in government affairs within the pharmaceutical industry, focusing on Brazil, Argentina, Chile, and Uruguay. They achieved significant milestones, such as treating and curing 80,000 patients with hepatitis C through Gilead's Sovaldi. Roni held various roles at organizations including Gilead Sciences and Shire Pharmaceuticals, and has contributed to the approval and reimbursement of treatments like Harvoni and Epclusa in under two years. Roni holds multiple degrees, including a Master in Epidemiology and Health Economics from Universidade Federal de São Paulo.
Location
Brasília, Brazil
This person is not in any teams
This person is not in any offices